EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    Quantum Dot: The Future of Personalized Medicine

    Cancer is amongst the most significant health hazards around the globe Individualized chemotherapy offers promise for the forthcoming cancer therapy in clinical practice with each patient receiving tailored medication based on essential biological aspects of a specific tumor One of the most pressing issues is the development of innovative ways for personalized

    Circular Logistics: A Strategic Advantage for U.S. Pharmaceutical Supply Chains in an Era of Uncertainty

    Temperaturerelated failures are estimated to cost the industry billion annually highlighting a nonnegotiable requirement for reliability product integrity and regulatory compliance For manufacturers

    Regulatory Challenges in Clinical Testing for New Pharmaceuticals

    The clinical testing is a stage where the new pharmaceutical products are a trial on human beings or patients The aims of clinical trials are to assess the effectivenesssafetytolerability or intolerance of new drug in man Generally clinical trials are conducted in phases each phase has different questions regarding the drug

    Why is Pharmacogenetics and Pharmacogenomics Important?

    In a world of increasingly personalized medicine the fields of pharmacogenetics and pharmacogenomics are gaining importance These disciplines explore the relationship between an individuals genetic makeup

    The Architect of the Void: When 3D Printing Becomes the Body’s New Bone

    In the quiet pressurised hum of a modern surgical suite a surgeon holds a highdefinition scan of a young patients femur On the screen a jagged dark shadow marks where an osteosarcoma has claimed its territory For decades the script for this moment has been written in cold hard steel

    Robotic Process Automation: The Catalyst for Pharma 4.0 Evolution

    The pharmaceutical industry is experiencing a massive shift to new era phase known as Industry or less commonly known as Pharma in this context In the middle of this transformational journey we have Robotic Process Automation RPA as a tool that is disruptive in the way these pharmaceutical organizations are run and managed

TOP ARTICLES

  • 3

    Why is Pharmacogenetics and Pharmacogenomics Important?

    Kate Williamson

    Pharmacogenetics and pharmacogenomics, exploring genetic influences on drug response, are pivotal in personalized medicine. By tailoring treatments to individual genetic makeup, these fields enhance d...

press releases Read more...

FairJourney Bio Delivers Antibody Engineering for Novel Tumor-Conditional IL-12 Therapeutic Approach That Unlocks the Potential of Localized Cytokine Activation

FairJourney Bio FJBio a global antibody discovery expert today announced the publication of a peerreviewed study in mAbs describing a novel approach with the potential to improve the therapeutic window of IL

Ipsen completes acquisition of Kartos Therapeutics, strengthening late-stage Oncology pipeline

Ipsen announced today it has completed the acquisition of Kartos Therapeutics a clinicalstage biopharmaceutical company adding latestage MDM inhibitor navtemadlin in Phase III clinical development in myelofibrosis

Galen and POA Pharma unveil Galsana, a new global brand for rare metabolic diseases

At the SSIEM Annual Symposium in Helsinki Galen Ltd and POA Pharma announced the launch of Galsana a new global brand for their metabolic product portfolio bringing together established products

Infex Therapeutics to present new RESP-X Phase IIa data in late-breaking session at ERS Congress 2026

Infex Therapeutics a leading antiinfectives specialist today announced that new Phase IIa study data for RESPX INFEX its firstinclass antivirulence monoclonal antibody therapy in development for NCFB patients

19 - 21

Aug 2026

20 - 21

Aug 2026

20 - 21

Aug 2026

20 - 21

Aug 2026

25 - 27

Aug 2026

CPHI Korea 2026

COEX, Seoul, Korea

26 - 27

Aug 2026

BIOMEDevice 2026

Boston Convention & Exhibition...

03 - 05

Sep 2026

5th MENA Congress for Rare Diseases 2026

Beach Rotana Hotel, Abu Dhabi,...

LATEST NEWS Read more...

Lupin and Tenpoint Therapeutics partner to commercialise YUVEZZI™ across European markets

Lupin Limited has announced that its wholly owned subsidiary VISUfarma BV has entered into an exclusive licensing agreement with Visus Therapeutics Inc a wholly owned subsidiary of Tenpoint Therapeutics Holding Limited

Rein Therapeutics receives US FDA Fast Track designation for LTI-03 in idiopathic pulmonary fibrosis

Rein Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for LTI an investigational treatment being developed for idiopathic pulmonary fibrosis IPF

IDEAYA Biosciences Announces Clinical Collaboration with Genentech for MTAP-Deleted, KRAS G12D-Mutant Pancreatic Cancer

IDEAYA Biosciences Inc NASDAQ IDYA has entered into a clinical collaboration with Genentech a member of the Roche Group to evaluate IDE in combination with GDC RG in patients

NTx Bio Supports Baylor College of Medicine in Manufacturing Personalised Cancer Vaccine for Phase 1 Melanoma Trial

NTx Bio is supporting Baylor College of Medicine in the manufacturing of a personalised cancer vaccine being evaluated in Diakonos Oncologys Phase trial for patients with refractory melanoma

VectorBuilder and Lir Therapeutics partner to advance AAV capsids for clinical development

VectorBuilder and Lir Therapeutics have entered into a strategic collaboration to develop adenoassociated virus AAV capsids that combine strong biological performance with the manufacturing and scalability requirements needed for clinical development

Cytovance Biologics launches standalone analytical services for biologics development

Cytovance Biologics has expanded its analytical services portfolio to provide standalone analytical support for biotechnology and pharmaceutical companies The new offering gives clients access to Cytovances analytical expertise and regulatoryready solutions without requiring a manufacturing engageme...